Literature DB >> 9305652

Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.

X Wu1, H Liu, H Xiao, J A Conway, E Hunter, J C Kappes.   

Abstract

The expression and incorporation of retroviral enzymes into virions in the form of Gag/Pol precursor polyproteins is believed to be important for the assembly of infectious viral particles. HIV-1 encodes a 160 kDa Gag/Pol precursor that includes Gag, protease (PR), reverse transcriptase (RT) and integrase (IN). We have developed the use of HIV accessory proteins (Vpr and Vpx) as vehicles to incorporate protein of both viral and non-viral origin into virions by expression in trans as heterologous fusion proteins (Wu et al., 1995, 1996a). To analyze the role of Gag/Pol in the formation of infectious virions, we incorporated RT and IN into HIV-1 particles in trans, as fusion partners of viral protein R (Vpr). Virions derived from an RT and IN minus proviral clone were infectious and replicated through a complete cycle of infection when RT and IN proteins were provided in trans. These results demonstrate that functional RT and IN proteins can be provided in trans, and that their expression and incorporation into virions as components of Gag/Pol are not required for the formation of infectious virions. Thus, for the first time, we have demonstrated for a human pathogenic retrovirus that processes of assembly and the function of critical viral enzymes can be unlinked. This finding will provide unique opportunities to explore retroviral RT/IN function and the role of Gag/Pol in the formation of infectious virions in the context of a replicating virus (in vivo).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9305652      PMCID: PMC1170145          DOI: 10.1093/emboj/16.16.5113

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  20 in total

Review 1.  The retroviral enzymes.

Authors:  R A Katz; A M Skalka
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

2.  Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain.

Authors:  T Masuda; V Planelles; P Krogstad; I S Chen
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 3.  tRNAs as primer of reverse transcriptases.

Authors:  R Marquet; C Isel; C Ehresmann; B Ehresmann
Journal:  Biochimie       Date:  1995       Impact factor: 4.079

4.  Analysis of human immunodeficiency virus type 1 integrase mutants.

Authors:  M A Ansari-Lari; L A Donehower; R A Gibbs
Journal:  Virology       Date:  1995-08-01       Impact factor: 3.616

5.  Genetic analysis of the human immunodeficiency virus type 1 integrase protein.

Authors:  C G Shin; B Taddeo; W A Haseltine; C M Farnet
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection.

Authors:  A D Leavitt; G Robles; N Alesandro; H E Varmus
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

7.  Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication.

Authors:  A Engelman; G Englund; J M Orenstein; M A Martin; R Craigie
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.

Authors:  H Liu; X Wu; M Newman; G M Shaw; B H Hahn; J C Kappes
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

9.  A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes.

Authors:  S K Ghosh; P N Fultz; E Keddie; M S Saag; P M Sharp; B H Hahn; G M Shaw
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

10.  Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.

Authors:  X Wu; H Liu; H Xiao; J Kim; P Seshaiah; G Natsoulis; J D Boeke; B H Hahn; J C Kappes
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  60 in total

1.  Ty3 integrase is required for initiation of reverse transcription.

Authors:  M Henrietta Nymark-McMahon; Nadejda S Beliakova-Bethell; Jean-Luc Darlix; Stuart F J Le Grice; Suzanne B Sandmeyer
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Biochemical analyses of the interactions between human immunodeficiency virus type 1 Vpr and p6(Gag).

Authors:  Y Jenkins; O Pornillos; R L Rich; D G Myszka; W I Sundquist; M H Malim
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

3.  The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles.

Authors:  Guney Boso; Claes Örvell; Nikunj V Somia
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

4.  Integrase-lexA fusion proteins incorporated into human immunodeficiency virus type 1 that contains a catalytically inactive integrase gene are functional to mediate integration.

Authors:  M L Holmes-Son; S A Chow
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus.

Authors:  Xiang Li; Yasuhiro Koh; Alan Engelman
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

6.  Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.

Authors:  H Liu; X Wu; H Xiao; J A Conway; J C Kappes
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

7.  Replication of chimeric human immunodeficiency virus type 1 (HIV-1) containing HIV-2 integrase (IN): naturally selected mutations in IN augment DNA synthesis.

Authors:  Marcus Padow; Lilin Lai; Champion Deivanayagam; Lawrence J DeLucas; Robert B Weiss; Diane M Dunn; Xiaoyun Wu; John C Kappes
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 8.  Virological and cellular roles of the transcriptional coactivator LEDGF/p75.

Authors:  Manuel Llano; James Morrison; Eric M Poeschla
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

9.  Virion-targeted viral inactivation of human immunodeficiency virus type 1 by using Vpr fusion proteins.

Authors:  G P Kobinger; A Borsetti; Z Nie; J Mercier; N Daniel; H G Göttlinger; A Cohen
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Stability of HIV Frameshift Site RNA Correlates with Frameshift Efficiency and Decreased Virus Infectivity.

Authors:  Pablo Garcia-Miranda; Jordan T Becker; Bayleigh E Benner; Alexander Blume; Nathan M Sherer; Samuel E Butcher
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.